Five-year results of arthroscopic techniques for the treatment of acetabular chondral lesions in femoroacetabular impingement by Donato Mancini & Andrea Fontana
ORIGINAL PAPER
Five-year results of arthroscopic techniques
for the treatment of acetabular chondral lesions
in femoroacetabular impingement
Donato Mancini & Andrea Fontana
Received: 18 April 2014 /Accepted: 30 May 2014 /Published online: 21 June 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Purpose This study assesses and compares the clinical out-
comes of the arthroscopic matrix-induced autologous chon-
drocyte implant (MACI) and autologous matrix-induced
chondrogenesis (AMIC) techniques for the treatment of ace-
tabular chondral defects between 2 and 4 cm2 consequent to
femoral acetabular impingement.
Methods Fifty-seven consecutive patients were treated with
the MACI (n=26) or AMIC (n=31) technique. Patients were
assessed pre-operatively and up to five years using the mod-
ified Harris Hip Score (mHHS) to compare outcomes.
Results In both the MACI and AMIC groups, significant hip
score improvements were measured over baseline levels at six
months post-op (81.2±8.4 for MACI, 80.3±8.3 for AMIC,
both p<0.001). The mHHS continued to improve up to three
years post-op and remained stable over time until the final five
year follow-up. Statistically significant differences between
the groups were not observed. The meanmHHS improvement
at the five year follow-up with respect to preoperative level
was 37.8±5.9 and 39.1±5.9 in patients who underwent MACI
and AMIC, respectively (NS). Subgroup analysis of both
MACI and AMIC treatment outcomes for patients with an
initial chondral defect larger than 3 cm2 yielded comparable
results at each time point.
Conclusions This study suggests that both arthroscopic
MACI and AMIC are valid procedures to repair medium-
sized chondral defects on the acetabular side of the hip found
during treatment of femoroacetabular impingement. Due to its
high sustainability and minimal invasiveness, the single-stage
AMIC procedure can reduce total treatment time and mini-
mise morbidity while providing the same beneficial effects as
the two-stage MACI intervention.
Keywords Hip arthroscopy .MACI technique . AMIC
technique . Acetabular chondral defects
Introduction
Femoroacetabular impingement (FAI) is a common cause of
hip pain most frequently affecting athletes and active young
individuals [1–4]. Although FAI is often compounded by
acetabular cartilage damage and labral lesions, rapid return
to health is of personal and economic importance, particularly
in such patient groups [5–7]. Choice of treatment option to
repair cartilage defects in the hip depends on the size and
severity of the injury. Specifically, small, partial thickness
defects are often treated with arthroscopic debridement [1],
whereas full-thickness defects smaller than 2 cm2 are gener-
ally treated with microfracture (MFx) and show good out-
comes [1, 8–10]. Indeed, most patients treated with MFx
realise complication-free functional improvement, are able to
resume an active lifestyle and return to sport [11, 12]. Con-
versely, MFx is known to be less effective in patients with
larger chondral lesions (2–4 cm2) or early osteoarthritis [13].
In the knee and talus, large chondral defects are success-
fully treated with autologous chondrocyte implantation (ACI)
or matrix-associated autologous chondrocyte implantation
(MACI) [14–22]. ACI has also been effectively used in the
hip. Both ACI and MACI are two-stage techniques where
chondrocytes are harvested from the patient, cultured and then
returned to the patient in a second surgical intervention.
Autologous matrix-induced chondrogenesis (AMIC) is a
single-stage procedure combining MFx with the use of a
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collagen I/III matrix (Chondro-Gide, Geistlich Pharma AG,
Wolhusen, Switzerland). Through MFx, the chondrogenic
blood clot formed containing cells, cytokines and growth
factors is stabilised and protected by the collagen matrix.
AMIC has been used to successfully repair chondral and
osteochondral defects of the knee [23–25], talus [22, 26] and
hip [27, 28].
The aim of this study was to evaluate and compare the
long-term performance and efficacy of MACI and AMIC for
the treatment of mid-sized acetabular chondral lesions (2–
4 cm2) found during arthroscopic treatment of FAI in a group
of selected patients.
Materials and methods
Between 2002 and 2008, 143 patients underwent arthroscopic
MACI or AMIC procedures for the treatment of acetabular
chondral lesions, all performed by the same senior surgeon.
These techniques were used to repair grade III and IV
(Outerbridge classification) [29] acetabular chondral lesions,
mostly located in the superior chondral acetabulum, conse-
quent to FAI. Of the 143 patients, this retrospective, non-
randomised study includes 57 consecutive patients who satis-
fied the following inclusion/exclusion criteria. Patients be-
tween the age of 18 and 50 with acetabular chondral lesion
size between 2 and 4 cm2 with radiological Tönnis degree <2
who were followed up to five years were included. Patients
with concomitant presence of femoral head chondral lesion
(kissing lesion), systemic rheumatoid diseases, dysplasia,
femoral neck axial deviations, coxa profunda and/or protrusio
acetabuli were excluded. Among these 57 patients, 26 were
treated with MACI (from November 2002 to June 2005) and
31 with AMIC (from November 2004 to June 2007) (Fig. 1).
In the overlapping period during which both techniques were
used, six patients were treated withMACI and 15 with AMIC.
The choice to treat a patient either with AMIC or MACI was
made on an economic basis.
For all patients, the primary indication for surgery was FAI
diagnosed with the aid of standard anteroposterior (AP) and
Dunn view radiographs and magnetic resonance imaging
(MRI), in accordance with commonly accepted criteria
[30–33]. For cam-type impingement, arthroscopic femoral
head-neck resection arthroplasty was performed to eliminate
the bony prominence that impinges the labrum and acetabular
rim and to restore the anatomic offset between the femoral
head and neck. In case of pincer-type impingement, arthro-
scopic acetabular rim trimming was performed to reduce the
bony overhang and to reshape the acetabulum into its normal
contour. An eventual detached labrum was reattached to the
superior acetabular rim with suture anchors. Mixed cam-
pincer impingements have been surgically addressed for both
pathologies. Dynamic tests were performed moving the hip
along its full range of motion checking the absence of any
remaining bony impingement [34, 35].
Surgical technique
MACI Following the arthroscopic diagnosis of chondral dam-
age, a cartilage biopsy from the area surrounding the pulvinar
was taken. Chondrocytes were isolated, expanded and seeded
onto a polymer scaffold composed of fibrin, polylactic/
polyglycolic acid and polydioxanone (Bioseed-C, BioTissue
AG, Freiburg, Germany). About three weeks thereafter, in a
second intervention, graft implantation was performed
arthroscopically as previously described [36]. Briefly, the
chondral defect was accurately debrided and fibrous tissue
removed to expose the subchondral bone. Care was taken to
create clear margins between the healthy cartilage and the
lesion in order to properly measure the chondral defect with
an arthroscopic probe. After removing the fluids from the joint
space by continuous aspiration, the cellular matrix was
trimmed to the size and shape of the chondral defect area,
inserted using an arthroscopic cannula and the lesion was
covered (Fig. 2).
AMIC This procedure was performed arthroscopically in a
single surgical stage as previously described [24]. During
the procedure a resorbable collagen I/III matrix (Chondro-
Gide, Geistlich Pharma AG, Wolhusen, Switzerland) was
placed to cover the acetabular chondral defect, after MFx of
the subchondral bone. Briefly, the chondral defect was mea-
sured with an arthroscopic probe and standard MFx was
carried out. Bone marrow bleeding from the holes was veri-
fied after removing the fluids from the joint space by contin-
uous aspiration. Destroyed and unstable cartilage was re-
moved using angled curettes or motorised shavers to achieve
a well-contained defect. The Chondro-Gide matrix was cut to
fit the size and the shape of the lesion and placed on the
chondral defect with the porous layer facing the bone surface
through an arthroscopic cannula (Fig. 3).
The post-operative rehabilitation programme was iden-
tical for both groups. On the first post-op day, patients
began rehabilitation with isotonic and isometric quadriceps
and gluteus contractions. Walking was allowed with the aid
of two crutches with partial weight-bearing (30 % of body
weight) on the operated leg for three weeks. Cycling exer-
cises started from post-operative day two, whereas swim-
ming was allowed after three weeks. At four weeks post-
op, walking with the aid of one crutch opposite to the
recovering leg was allowed for seven days, then normal
walking thereafter. Impact sport activity could resume at
three months post-op and complete return to sport activi-
ties was allowed six months after surgery.
All patients were assessed preoperatively and at follow-up
after six, 12, 24, 36, 48 and 60 months using the modified
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Harris Hip Score (mHHS) [37]. The mHHS assesses hip
function with a maximum score of 91. Our results were rated
as follows: excellent (81–91), good (71–80), fair (61–70) and
poor (less than 60) [38]. Follow-up radiographic exams were
only conducted in symptomatic patients. MRI assessment was
not performed due to non-coverage by the health insurances
and second-look arthroscopy was not allowed by the Institu-
tional Review Board (IRB). The study was approved by the
IRB of the Institute and all patients gave their consent to the
data collection and publication.
Fig. 1 CONSORT flow chart for
patient enrolment
Fig. 2 Arthroscopic view of MACI procedure Fig. 3 Arthroscopic view of the final phase of the AMIC procedure
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Statistical analysis
Comparison of the groups was performed using the two-way
analysis of variance for repeated treatment time values. Vari-
ance analysis was preceded by a homogeneity of variances
test (Mauchly’s and Levene’s) to verify the pertinence of
parametric statistical methods. All analyses were done using
the software package SPSS 11.0 and p<0.05 was considered
statistically significant. Data are reported as mean±standard
deviation, unless otherwise indicated.
Results
A total of 57 patients, of which 26 underwent MACI and 31
AMIC, were clinically evaluated during the five year follow-
up. Patient characteristics including demographics and defect
assessments were comparable between the two groups (Ta-
ble 1). In particular, the average age was comparable (36±
9.3 years for MACI and 36.4±10.3 years for AMIC, NS) as
well as the mean defect size (2.8±0.7 cm2 and 2.9±0.8 cm2
for MACI and AMIC, respectively, NS). Pre-operative mHHS
was also similar between the groups, with mean scores of 46.5
±7 for the MACI group and 44.9±5.9 for the AMIC group
(NS). In the overlapping period during which MACI and
AMIC were both performed (6 MACI and 15 AMIC), alloca-
tion into each treatment group did not affect the homogeneity
of each group as the mean lesion size for these subgroups was
comparable and similar to the respective whole population
(2.8±1 and 2.8±0.8 for MACI and AMIC, respectively, NS; a
lesion smaller than 3 cm2 accounted for 50 % in the MACI
group and 53 % in the AMIC group).
Significant improvement, as measured by the mHHS, was
observed in both groups at 6 months in comparison to preop-
erative levels (81.2±8.4 for MACI and 80.3±8.3 for AMIC,
both p<0.001), with no significant difference between the
groups. Continuous improvement with respect to each previ-
ous evaluation time point was seen, reaching the highest
improvement level at the three year follow-up in both groups
(85.5±7.4 and 85.5±7.2 for MACI and AMIC, respectively).
The mHHS then remained stable over time until the final five
year follow-up, without any significant differences between
the two groups. At each of the 12-, 24-, 36-, 48- and 60-month
time points, the mHHSwas significantly higher in comparison
to the six month values in both groups (Fig. 4). The mean
mHHS improvement recorded at the five year follow-up com-
pared with preoperative scores was 37.8±5.9 and 39.1±5.9
for MACI and AMIC, respectively, without any significant
difference between the groups (NS) (Fig. 5). No patient had a
poor post-operative mHHS (all >60). No significant differ-
ences were observedwhen comparing the subgroups ofMACI
and AMIC patients with an initial chondral defect larger than
3 cm2 at all time points. In these moderately large defects, the
mHHS of both subgroups significantly improved with respect
to pre-operative values by six months post-op (82.8±8.9 for
MACI and 80.3±8.9 for AMIC). In the subgroup of lesions
larger than 3 cm2 of both MACI and AMIC treatment groups,
the improvements achieved by the three year time point were
maintained at least up to the five year follow-up (85.2±8.1
and 83.2±8.5 for MACI and AMIC, respectively).
Second-look arthroscopy was performed incidentally in a
patient treated with the AMIC technique. In this case,
13months after surgery, the patient experienced haemorrhagic
bursitis due to a fall occurring during a marathon. During the
arthroscopic bursectomy, regenerated tissue with a
fibrocartilage-like aspect and consistency was observed cov-
ering the whole defect (Fig. 6).
No adverse event was observed and no failure resulting in
hip arthroplasty was detected in any of these patients during
the five year follow-up.
Discussion
To the best of our knowledge, this is the first study comparing
long-term clinical outcomes up to five years in patients with
medium-sized acetabular chondral defects resulting from FAI
treated with the MACI or AMIC technique. Our results show
comparable long-term clinical outcomes for repair of 2–4 cm2
lesions with both MACI and AMIC, as assessed by mHHS.
No impairment over time for either group could be seen.
Instead, significant improvements were observed in both treat-
ment groups up to the three year follow-up.
Table 1 Baseline characteristics
of the study groups MACI (n=26) AMIC (n=31) p
Sex (M/F) 12/14 13/18 NS
FAI-cam (n) 16 21 NS
FAI-pincer (n) 13 16 NS
FAI-combined (n) 3 6 NS
Preoperative mean age (years) 36±9.3 (19–50) 36.4±10.3 (19–50) NS
Preoperative mean defect size (cm2) 2.8±0.7 (2–4) 2.9±0.8 (2–4) NS
Preoperative mean mHHS 46.5±7 (36–62) 44.9±5.9 (38–60) NS
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Moreover, subgroup analysis of patients presenting larger
lesions (>3 cm2) yielded similar therapeutic outcomes be-
tween both treatment groups, demonstrating that AMIC can
be reliably extended to 4 cm2 defects. Several arthroscopic
techniques have been used to treat full-thickness chondral
defects of the hip in the past few decades. However, due to
the more recent introduction of arthroscopy in the hip joint for
FAI, published outcome studies on hip cartilage repair are
scarce and comprehensive evidence-based treatment guide-
lines for chondral lesions of the hip remain to be defined.
MFx is still currently the first choice treatment for both
acetabular and femoral head small chondral defects (≤2 cm2)
as it is not invasive and very rarely has it been associated with
major post-operative complications. Satisfactory clinical re-
sults after MFx of the hip [9, 13, 39–41], including athletes
[10, 42], have been recently reported; however, the follow-up
reported for MFx in the hip did not exceed two years [10, 40,
43]. In comparison, knee MFx, which is also known to be
effective for lesions ≤2 cm2, has seen 47–80 % of cases
reporting deterioration of knee function after two years [44].
Thus, clinical data relating lesion size, treatment choice and
evaluation of cartilage repair procedures beyond two years are
of critical importance to determine predictable and sustainable
therapy for chondral cartilage defects of the hip.
Literature on the use of MACI for the treatment of
medium-sized chondral defects in the hip is particularly
scarce. The first case report by Akimau and colleagues [45]
described the treatment of an extensive loss of cartilage and
osteonecrosis in the hip treated with bone grafting and MACI
using Chondro-Gide. Sixteen months after the procedure, the
patient showed satisfactory clinical improvement and was
able to return to daily activities. Another report described a
Fig. 4 Pre-operative mHHS and
up to 5 years after MACI and
AMIC procedures
Fig. 5 mHHS differences
between follow-up and
preoperative level for MACI and
AMIC procedures
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patient who underwent MACI in the presence of a full-
thickness loss around the osteochondral plugs consequent to
autologous osteochondral mosaicplasty [46]. At the two year
follow-up, the patient was pain-free and MRI showed good
tissue repair with normal joint space. These limited results
have been supported by a larger controlled retrospective study
comparing arthroscopic MACI with debridement for the treat-
ment of grade III/IV (according to Outerbridge) acetabular
and femoral head chondral defects larger than 2 cm2. A total of
30 patients were equally distributed in the two treatment
groups, assessed at six months post-operatively and then yearly
up to five years using the HHS. The results showed signifi-
cantly better outcomes in the MACI group with respect to
debridement at all evaluation time points. At the last follow-
up, the HHSwas 87.4 and 56.3 for theMACI and debridement
groups, respectively. The best results were recorded in patients
with acetabular defects treated with MACI and the positive
outcomes were maintained over time. Despite these encourag-
ing results about the use ofMACI for the treatment of chondral
defects of the hip, this technique is not associated with negli-
gible donor site morbidity [47]. Further, partial chondrocyte
dedifferentiation during two-dimensional in vitro expansion
can result in the formation of fibrocartilage-like tissue once
the graft is implanted [48]. Moreover, the MACI procedure is
cost intensive because it requires two surgical interventions,
and from a regulatory point of view, it is included in the so-
called advanced therapy medicinal products (ATMPs) neces-
sitating a more complex approval process.
Some of the MACI drawbacks can be overcome by AMIC,
especially for the treatment of patients with medium-sized
chondral defects. The AMIC technique spares donor site
morbidity since effective cartilage regeneration can be stimu-
lated in a single surgical intervention without the need for
harvesting cells from a second site. AMIC exploits the regen-
erative potential of mesenchymal progenitor cells deriving
from subchondral bone. The collagen type I/III matrix used
in AMIC protects the blood clot and supplies the regenerating
site with a proper microenvironment supporting cell adhesion,
growth and differentiation. Collagen matrices have previously
been shown to support chondrogenic differentiation of mes-
enchymal stem cells [49] and to maintain chondrocyte pheno-
type [50], in particular when the matrix is composed of colla-
gen types I and III [51]. The AMIC technique is further
beneficial because it eliminates the need for specialised cen-
tres and laboratory support to cultivate cells, in turn reducing
total therapy time and overall cost, compared to two-stage
procedures such as MACI.
Our findings are in line with the results deriving from the
treatment of cartilage defects of the knee and talus with the
AMIC technique [23–25, 52]. Gille et al. [24] showed that
patients affected by large grade IV (according to Outerbridge)
chondral lesions experienced significant improvement in
terms of five different evaluation scores at 12 months and up
to 24 months after the AMIC procedure. Similar results were
also found in a larger multicentre observational study includ-
ing patients with grade III or IV chondral lesions, evaluated at
the two year follow-up. Satisfactory outcomes were also re-
ported for osteochondral lesions of the talus treated by AMIC
[53] and confirmed in another study with a three year follow-
up [22]. In addition, Wiewiorski and colleagues showed that,
although neo-formed cartilage resulting fromAMIC treatment
of osteochondral lesions of the talus presents a significantly
lower glycosaminoglycan content than normal hyaline carti-
lage, it can be considered as possessing hyaline-like properties
[53].
Until now, long-term outcome data for the treatment of
chondral defects of the hip utilising the MACI and AMIC
methods were not available. Nevertheless, several studies in
the knee showed that the MFx technique is associated with
excellent short-/medium-term clinical outcomes [54, 55]
which tend to decline over time. For this reason we examined
the AMIC technique, which can be considered an evolution of
the MFx technique, for its potential to overcome the problem
of transient positive clinical outcomes. Our data demonstrate
sustainable positive outcomes, reflected by highmHHS over a
5-year follow-up period, for patients who underwent AMIC or
MACI procedures.
One of the limitations of our study is that it is a
retrospective analysis of data collected over years of treat-
ment. Patients were not randomised, but despite this, the
patient baseline characteristics were comparable between
groups. Another limitation is that clinical improvement
was judged based only on the mHHS. Although this test
has high validity and reliability [37], it is most suitable for
assessment of functionality in elderly arthritic patients and
might not be sensitive enough to assess subtle changes in
function in young, otherwise healthy patients. Neverthe-
less, the improvement in these scores suggests that both
MACI and AMIC provide clinical benefits to patients
affected by a chondral lesion consequent to femoral ace-
tabular impingement.
Fig. 6 Second look of an AMIC patient 13 months after surgery
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Finally, for ethical reasons, no biopsy of the neo-
regenerated tissue was performed and thus histological data
of the neo-tissue are not available. An incidental second look
was however performed in a patient who underwent AMIC
13 months previously. Here, a satisfactory tissue quality with
the fibrocartilage-like aspect was observed.
In conclusion, both the MACI and AMIC techniques
allowed a marked clinical improvement in patients affected
by chondral defects due to FAI, without significant differences
between the two groups. This study suggests that both MACI
and AMIC are valid procedures to repair medium-sized
chondral defects on the acetabular side of the hip found during
treatment of FAI and lead to long-term favourable outcomes.
AMIC, due to its minimal invasiveness, single-stage proce-
dure and proven safety, may be favoured with respect to
minimising therapy time and cost. Accordingly, ongoing stud-
ies from our group intend to further investigate the clinical and
economic benefits of the AMIC technique.
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